First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis
Loading...
Date
Authors
Renders, L.
Budde, K.
Rosenberger, C.
Swelm, R.P.L. Rachel
Swinkels, D.W. Dorine
Dellanna, F.
Feuerer, W.
Wen, M.
Erley, C.
Bader, B.